SPECTRONRX Trademark

Trademark Overview


On Wednesday, April 16, 2025, a trademark application was filed for SPECTRONRX with the United States Patent and Trademark Office. The USPTO has given the SPECTRONRX trademark a serial number of 99140367. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 11, 2025. This trademark is owned by Nukemed, Inc.. The SPECTRONRX trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Treatment of materials by means of therapeutic and diagnostic development and engineering of pharmaceuticals
spectronrx

General Information


Serial Number99140367
Word MarkSPECTRONRX
Filing DateWednesday, April 16, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTreatment of materials by means of therapeutic and diagnostic development and engineering of pharmaceuticals
Description of MarkThe mark consists of The word Spectron followed immediately with a capital R and stylized x.
Pseudo MarkSPECTRON RX

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, April 16, 2025
Primary Code040
First Use Anywhere DateWednesday, July 1, 2020
First Use In Commerce DateWednesday, July 1, 2020

Trademark Owner History


Party NameNukemed, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46268

Trademark Events


Event DateEvent Description
Wednesday, April 16, 2025NEW APPLICATION ENTERED
Wednesday, April 16, 2025APPLICATION FILING RECEIPT MAILED
Monday, August 25, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 11, 2025ASSIGNED TO EXAMINER
Thursday, September 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 11, 2025NON-FINAL ACTION E-MAILED
Thursday, September 11, 2025NON-FINAL ACTION WRITTEN